ELITE PHARMACEUTICALS INC

Company snapshot

Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two A

• 10 approved product(s) across US/EU regulatory metadata.
• 8 active pipeline program(s) linked via ClinicalTrials.gov.
• 26 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for ELITE PHARMACEUTICALS INC. Not investment advice.

• approval Jun 2, 2026

  Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product

Recent activity

Latest pipeline, patent, and corporate events for ELITE PHARMACEUTICALS INC.

1. Jun 8, 2026 Clinical update

   LBS-008-CT05 — Phase 3

2. Jun 8, 2026 Clinical update

   Rocuronium — Approved

3. Jun 8, 2026 Clinical update

   Rocuronium Bromide — Approved

4. Jun 8, 2026 Clinical update

   Oxycodone/Naltrexone Capsules — Phase 3

5. Jun 8, 2026 Clinical update

   Oxycodone Naltrexone (a) — Phase 3

View all clinical trial activity →

• What is ELITE PHARMACEUTICALS INC?

  ELITE PHARMACEUTICALS INC is a pharma organization headquartered in Northvale, USA. It trades on NYSE under ticker ELTP. Primary therapeutic focus areas include Stargardt Disease, Muscle Relaxation, Geographic Atrophy, Diabetes Mellitus, Type 2, Pain. NovaPharmaNews links 8 clini

• Is ELITE PHARMACEUTICALS INC publicly traded?

  Yes. ELITE PHARMACEUTICALS INC is listed with ticker ELTP on NYSE per SEC EDGAR records linked on this profile.

• What drugs does ELITE PHARMACEUTICALS INC develop or market?

  We link 24 drug profile(s) where ELITE PHARMACEUTICALS INC is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/elite-pharmaceuticals-inc-nv#company-drugs.

• What are the latest developments for ELITE PHARMACEUTICALS INC?

  In the last 12 months our linked public records show 8 trial program update(s) and 1 US patent grant(s) tied to this profile.

• What therapeutic areas does ELITE PHARMACEUTICALS INC focus on?

  ELITE PHARMACEUTICALS INC focuses on Stargardt Disease, Muscle Relaxation, Geographic Atrophy based on our analysis of their pipeline programs and drug development activities.